Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.51 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.48 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 2/20 | 0.43 |
| ▸ | PKM | P14618 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | CA2 | P00918 | 2/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | CA1 | P00915 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15592739 | 1.00 | LMNA (0.51) | LMNARNPEPFOLH1ALDH1A1NPSR1 | |
| Acrylic Acid SCHEMBL7578602 | 0.90 | LMNA (0.44) | LMNARNPEPFOLH1ALDH1A1NPSR1 | |
| SCHEMBL8928051 | 0.90 | RNPEP (0.54) | LMNARNPEPFOLH1ALDH1A1NPSR1 | |
| SCHEMBL7229733 | 0.86 | RNPEP (0.47) | LMNARNPEPFOLH1ALDH1A1NPSR1 | |
| SCHEMBL29561871 | 0.86 | RNPEP (0.47) | LMNARNPEPFOLH1ALDH1A1NPSR1 | |
| SCHEMBL30642009 | 0.86 | RNPEP (0.47) | LMNARNPEPFOLH1ALDH1A1NPSR1 | |
| SCHEMBL8254544 | 0.86 | RNPEP (0.47) | LMNARNPEPFOLH1ALDH1A1NPSR1 | |
| SCHEMBL9194550 | 0.85 | RNPEP (0.55) | LMNARNPEPFOLH1ALDH1A1NPSR1 | |
| SCHEMBL17431202 | 0.84 | LMNA (0.41) | LMNARNPEPFOLH1ALDH1A1NPSR1 | |
| SCHEMBL19729236 | 0.84 | LMNA (0.41) | LMNARNPEPFOLH1ALDH1A1NPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114680234-B | Methionine hydroxy analogue isopropyl ester compound and preparation method and production system thereof | 天宝动物营养科技股份有限公司 | 2024-06-25 | — | — | CN | claimed |
| CN-117535357-A | Method for synthesizing liquid isopropyl methionine through enzymatic method | 广州智特奇生物科技股份有限公司 | 2024-02-09 | — | — | CN | claimed |
| CN-114680234-A | Methionine hydroxy analogue isopropyl ester compound and preparation method and production system thereof | 天宝动物营养科技股份有限公司 | 2022-07-01 | — | — | CN | claimed |
| CN-113979905-A | Method for synthesizing liquid isopropyl methionine | 山东新和成氨基酸有限公司 | 2022-01-28 | — | — | CN | claimed |
| CN-114680234-B | Methionine hydroxy analogue isopropyl ester compound and preparation method and production system thereof | 天宝动物营养科技股份有限公司 | 2024-06-25 | — | — | CN | disclosed |
| CN-114680234-B | Methionine hydroxy analogue isopropyl ester compound and preparation method and production system thereof | 天宝动物营养科技股份有限公司 | 2024-06-25 | — | — | CN | disclosed |
| CN-117535357-A | Method for synthesizing liquid isopropyl methionine through enzymatic method | 广州智特奇生物科技股份有限公司 | 2024-02-09 | — | — | CN | disclosed |
| CN-117535357-A | Method for synthesizing liquid isopropyl methionine through enzymatic method | 广州智特奇生物科技股份有限公司 | 2024-02-09 | — | — | CN | disclosed |
| CN-117535357-A | Method for synthesizing liquid isopropyl methionine through enzymatic method | 广州智特奇生物科技股份有限公司 | 2024-02-09 | — | — | CN | disclosed |
| CN-116802173-A | Process for the preparation of diastereomerically pure DL/LD-methionyl methionine | 赢创运营有限公司 | 2023-09-22 | — | — | CN | disclosed |
| US-20230183253-A1 | NANOMATERIAL COMPOSITIONS, SYNTHESIS, AND ASSEMBLY | RHODE ISLAND HOSPITAL | 2023-06-15 | — | — | US | disclosed |
| CN-114680234-A | Methionine hydroxy analogue isopropyl ester compound and preparation method and production system thereof | 天宝动物营养科技股份有限公司 | 2022-07-01 | — | — | CN | disclosed |
| US-20170362238-A1 | NANOMATERIAL COMPOSITIONS, SYNTHESIS, AND ASSEMBLY | RHODE ISLAND HOSPITAL | 2017-12-21 | — | — | US | disclosed |
| WO-2016081522-A1 | NANOMATERIAL COMPOSITIONS, SYNTHESIS, AND ASSEMBLY | RHODE ISLAND HOSPITAL (US) | 2016-05-26 | — | — | WO | disclosed |
| US-20130123465-A1 | MONOMETHYLVALINE COMPOUNDS HAVING PHENYLALANINE SIDE-CHAIN MODIFICATIONS AT THE C-TERMINUS | SEATTLE GENETICS, INC. (US) | 2013-05-16 | — | — | US | disclosed |
| US-8343928-B2 | Monomethylvaline compounds having phenylalanine side-chain replacements at the C-terminus | SEATTLE GENETICS, INC. (US) | 2013-01-01 | — | — | US | disclosed |
| US-8198458-B2 | Non-nucleoside reverse transcriptase inhibitors | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2012-06-12 | — | — | US | disclosed |
| US-7517998-B2 | Benzothiazole or benzothiazine derivative of dipyrido(2,3;b:2',3'-e) diazepin-6-one; viricide against human t-cell leukemia/lymphoma virus | BOEHRINGER INGELHEIM INTERNATIONAL GMBH | 2009-04-14 | — | — | US | disclosed |
| US-7517998-B2 | Benzothiazole or benzothiazine derivative of dipyrido(2,3;b:2',3'-e) diazepin-6-one; viricide against human t-cell leukemia/lymphoma virus | BOEHRINGER INGELHEIM INTERNATIONAL GMBH | 2009-04-14 | — | — | US | disclosed |
| US-20090018086-A1 | Monomethylvaline Compounds Having Phenylalanine Side-Chain Replacements at the C-Terminus | SEATTLE GENETICS, INC. (US) | 2009-01-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130123465-A1 | MONOMETHYLVALINE COMPOUNDS HAVING PHENYLALANINE SIDE-CHAIN MODIFICATIONS AT THE C-TERMINUS | MMAB, PTMS, DNPEP | LMNA 578/4885RNPEP 412/4885FOLH1 27/4885 |
| US-20090018086-A1 | Monomethylvaline Compounds Having Phenylalanine Side-Chain Replacements at the C-Terminus | MMAB, DNPEP, MARCKS | LMNA 616/4885RNPEP 393/4885FOLH1 24/4885 |
| US-20170362238-A1 | NANOMATERIAL COMPOSITIONS, SYNTHESIS, AND ASSEMBLY | POLRMT, NT5C3B, CHMP4B | LMNA 210/4885RNPEP 1698/4885FOLH1 1198/4885 |
| US-20230183253-A1 | NANOMATERIAL COMPOSITIONS, SYNTHESIS, AND ASSEMBLY | POLRMT, NT5C3B, CHMP4B | LMNA 210/4885RNPEP 1698/4885FOLH1 1198/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.